Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
出版年份 2019 全文链接
标题
Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
作者
关键词
-
出版物
Frontiers in Cell and Developmental Biology
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-05-15
DOI
10.3389/fcell.2019.00081
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
- (2018) Eytan M. Stein et al. BLOOD
- LSD1 inhibition exerts its antileukemic effect by recommissioning PU.1- and C/EBPα-dependent enhancers in AML
- (2018) Monica Cusan et al. BLOOD
- ORY-1001, a Potent and Selective Covalent KDM1A Inhibitor, for the Treatment of Acute Leukemia
- (2018) Tamara Maes et al. CANCER CELL
- Small molecules as tools to study the chemical epigenetics of lysine acetylation
- (2018) Matthias Schiedel et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Complexity of Blocking Bivalent Protein–Protein Interactions: Development of a Highly Potent Inhibitor of the Menin–Mixed-Lineage Leukemia Interaction
- (2018) Dmitry Borkin et al. JOURNAL OF MEDICINAL CHEMISTRY
- The dTAG system for immediate and target-specific protein degradation
- (2018) Behnam Nabet et al. Nature Chemical Biology
- Regulation of MLL/COMPASS stability through its proteolytic cleavage by taspase1 as a possible approach for clinical therapy of leukemia
- (2018) Zibo Zhao et al. GENES & DEVELOPMENT
- Structure-guided development of YEATS domain inhibitors by targeting π-π-π stacking
- (2018) Xin Li et al. Nature Chemical Biology
- Discovery of a Selective Inhibitor for the YEATS Domains of ENL/AF9
- (2018) Thomas Christott et al. SLAS Discovery
- The MLL recombinome of acute leukemias in 2017
- (2017) C Meyer et al. LEUKEMIA
- Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
- (2017) Loren M. Lasko et al. NATURE
- Transcription control by the ENL YEATS domain in acute leukaemia
- (2017) Michael A. Erb et al. NATURE
- ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia
- (2017) Liling Wan et al. NATURE
- Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells
- (2017) Robin M Meyers et al. NATURE GENETICS
- Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
- (2017) Takao Fujisawa et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia
- (2017) Andrei V. Krivtsov et al. Cold Spring Harbor Perspectives in Medicine
- Targeting Cancer Cells with BET Bromodomain Inhibitors
- (2017) Yali Xu et al. Cold Spring Harbor Perspectives in Medicine
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
- (2016) D. A. Arber et al. BLOOD
- Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic Leukemia
- (2016) Shan Lin et al. CANCER CELL
- SnapShot: Transcription Elongation
- (2016) Christine E. Cucinotta et al. CELL
- Deregulation of the HOXA9/MEIS1 axis in acute leukemia
- (2016) Cailin T. Collins et al. CURRENT OPINION IN HEMATOLOGY
- Inhibitors of LSD1 as a potential therapy for acute myeloid leukemia
- (2016) Amanda Przespolewski et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor
- (2016) Laetitia J. Martin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Complementary activities of DOT1L and Menin inhibitors in MLL-rearranged leukemia
- (2016) C Dafflon et al. LEUKEMIA
- Structural basis for activity regulation of MLL family methyltransferases
- (2016) Yanjing Li et al. NATURE
- Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition
- (2016) Anja F Hohmann et al. Nature Chemical Biology
- Functional interdependence of BRD4 and DOT1L in MLL leukemia
- (2016) Omer Gilan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- The molecular mechanics of mixed lineage leukemia
- (2016) R K Slany ONCOGENE
- LSD1: biologic roles and therapeutic targeting
- (2016) Alba Maiques-Diaz et al. Epigenomics
- ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia
- (2016) L. Zhu et al. Cancer Discovery
- Functional interdependence of BRD4 and DOT1L in MLL leukemia
- (2016) Omer Gilan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- MLL1 and MLL1 fusion proteins have distinct functions in regulating leukemic transcription program
- (2016) Jing Xu et al. Cell Discovery
- MLL leukemia induction by genome editing of human CD34+ hematopoietic cells
- (2015) C. Buechele et al. BLOOD
- Pharmacologic Inhibition of the Menin-MLL Interaction Blocks Progression of MLL Leukemia In Vivo
- (2015) Dmitry Borkin et al. CANCER CELL
- Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
- (2015) S. Picaud et al. CANCER RESEARCH
- The interplay of histone modifications - writers that read
- (2015) T. Zhang et al. EMBO REPORTS
- Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond
- (2015) Chun-Wei Chen et al. EXPERIMENTAL HEMATOLOGY
- Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
- (2015) Sheng F. Cai et al. MOLECULAR CELL
- BET Bromodomain Inhibition Suppresses the Function of Hematopoietic Transcription Factors in Acute Myeloid Leukemia
- (2015) Jae-Seok Roe et al. MOLECULAR CELL
- Transcriptional plasticity promotes primary and acquired resistance to BET inhibition
- (2015) Philipp Rathert et al. NATURE
- BET inhibitor resistance emerges from leukaemia stem cells
- (2015) Chun Yew Fong et al. NATURE
- DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia
- (2015) Chun-Wei Chen et al. NATURE MEDICINE
- Genomics in acute lymphoblastic leukaemia: insights and treatment implications
- (2015) Kathryn G. Roberts et al. Nature Reviews Clinical Oncology
- High-throughput functional genomics using CRISPR–Cas9
- (2015) Ophir Shalem et al. NATURE REVIEWS GENETICS
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Small Molecule Inhibitors of Bromodomain–Acetyl-lysine Interactions
- (2014) Michael Brand et al. ACS Chemical Biology
- A Series of Potent CREBBP Bromodomain Ligands Reveals an Induced-Fit Pocket Stabilized by a Cation-π Interaction
- (2014) Timothy P. C. Rooney et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nonclinical pharmacokinetics and metabolism of EPZ-5676, a novel DOT1L histone methyltransferase inhibitor
- (2014) Aravind Basavapathruni et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Lysine-specific demethylase 1 (LSD1) in hematopoietic and lymphoid neoplasms
- (2014) D. Niebel et al. BLOOD
- AF9 YEATS Domain Links Histone Acetylation to DOT1L-Mediated H3K79 Methylation
- (2014) Yuanyuan Li et al. CELL
- SIRT1 Activation by a c-MYC Oncogenic Network Promotes the Maintenance and Drug Resistance of Human FLT3-ITD Acute Myeloid Leukemia Stem Cells
- (2014) Ling Li et al. Cell Stem Cell
- Two decades of leukemia oncoprotein epistasis: the MLL1 paradigm for epigenetic deregulation in leukemia
- (2014) Bin E. Li et al. EXPERIMENTAL HEMATOLOGY
- Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
- (2014) Duncan A. Hay et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The Mechanisms behind the Therapeutic Activity of BET Bromodomain Inhibition
- (2014) Junwei Shi et al. MOLECULAR CELL
- Targeting bromodomains: epigenetic readers of lysine acetylation
- (2014) Panagis Filippakopoulos et al. NATURE REVIEWS DRUG DISCOVERY
- Erasers of Histone Acetylation: The Histone Deacetylase Enzymes
- (2014) E. Seto et al. Cold Spring Harbor Perspectives in Biology
- The SIRT1 Activator SRT1720 Extends Lifespan and Improves Health of Mice Fed a Standard Diet
- (2014) Sarah J. Mitchell et al. Cell Reports
- The Histone Methyltransferase Activity of MLL1 Is Dispensable for Hematopoiesis and Leukemogenesis
- (2014) Bibhu P. Mishra et al. Cell Reports
- The histone LSD1 demethylase in stemness and cancer transcription programs
- (2013) Stefano Amente et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Diverse functions of PHD fingers of the MLL/KMT2 subfamily
- (2013) Muzaffar Ali et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Distinct pathways regulated by menin and by MLL1 in hematopoietic stem cells and developing B cells
- (2013) B. E. Li et al. BLOOD
- Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
- (2013) S. R. Daigle et al. BLOOD
- Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l
- (2013) A. J. Deshpande et al. BLOOD
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation
- (2013) J. Shi et al. GENES & DEVELOPMENT
- Targeting Recruitment of Disruptor of Telomeric Silencing 1-like (DOT1L)
- (2013) Chenxi Shen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Medicinal Chemistry Perspective for Targeting Histone H3 Lysine-79 Methyltransferase DOT1L
- (2013) Justin L. Anglin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Acute lymphoblastic leukaemia
- (2013) Hiroto Inaba et al. LANCET
- Structural basis for high-affinity binding of LEDGF PWWP to mononucleosomes
- (2013) Jocelyn O. Eidahl et al. NUCLEIC ACIDS RESEARCH
- Breaking the LSD1/KDM1A Addiction: Therapeutic Targeting of the Epigenetic Modifier in AML
- (2012) Alyson A. Lokken et al. CANCER CELL
- The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells
- (2012) William J. Harris et al. CANCER CELL
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family
- (2012) Panagis Filippakopoulos et al. CELL
- Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l
- (2012) L Chen et al. LEUKEMIA
- Cell of origin determines clinically relevant subtypes of MLL-rearranged AML
- (2012) A V Krivtsov et al. LEUKEMIA
- Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia
- (2012) Tino Schenk et al. NATURE MEDICINE
- Epigenetic protein families: a new frontier for drug discovery
- (2012) Cheryl H. Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- The super elongation complex (SEC) family in transcriptional control
- (2012) Zhuojuan Luo et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Perceiving the epigenetic landscape through histone readers
- (2012) Catherine A Musselman et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- BRD4 is an atypical kinase that phosphorylates Serine2 of the RNA Polymerase II carboxy-terminal domain
- (2012) B. N. Devaiah et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing
- (2012) Madapura M. Pradeepa et al. PLoS Genetics
- The Pathogenesis of Mixed-Lineage Leukemia
- (2011) Andrew G. Muntean et al. Annual Review of Pathology-Mechanisms of Disease
- MLL fusion proteins preferentially regulate a subset of wild-type MLL target genes in the leukemic genome
- (2011) Q.-f. Wang et al. BLOOD
- Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation
- (2011) S. Y. Jo et al. BLOOD
- DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis
- (2011) A. T. Nguyen et al. BLOOD
- Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
- (2011) Scott R. Daigle et al. CANCER CELL
- MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
- (2011) Kathrin M. Bernt et al. CANCER CELL
- Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency
- (2011) R David Hawkins et al. CELL RESEARCH
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- A Small Molecule Binding to the Coactivator CREB-Binding Protein Blocks Apoptosis in Cardiomyocytes
- (2011) Jagat C. Borah et al. CHEMISTRY & BIOLOGY
- Pluripotency-related, Valproic Acid (VPA)-induced Genome-wide Histone H3 Lysine 9 (H3K9) Acetylation Patterns in Embryonic Stem Cells
- (2011) Hadas Hezroni et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activated K-Ras protein accelerates human MLL/AF4-induced leukemo-lymphomogenicity in a transgenic mouse model
- (2011) H Tamai et al. LEUKEMIA
- RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
- (2011) Johannes Zuber et al. NATURE
- Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia
- (2011) Mark A. Dawson et al. NATURE
- Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes
- (2011) D. Biswas et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Epigenetic Programs in MLL-Rearranged Leukemias
- (2011) K. M. Bernt et al. Hematology-American Society of Hematology Education Program
- A Higher-Order Complex Containing AF4 and ENL Family Proteins with P-TEFb Facilitates Oncogenic and Physiologic MLL-Dependent Transcription
- (2010) Akihiko Yokoyama et al. CANCER CELL
- The PAF Complex Synergizes with MLL Fusion Proteins at HOX Loci to Promote Leukemogenesis
- (2010) Andrew G. Muntean et al. CANCER CELL
- Histone H3 Lysine 79 Methyltransferase Dot1 Is Required for Immortalization by MLL Oncogenes
- (2010) M.-J. Chang et al. CANCER RESEARCH
- Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers
- (2010) Shinya Hayami et al. INTERNATIONAL JOURNAL OF CANCER
- Binding of the MLL PHD3 Finger to Histone H3K4me3 Is Required for MLL-Dependent Gene Transcription
- (2010) Pei-Yun Chang et al. JOURNAL OF MOLECULAR BIOLOGY
- Genetic aberrations in paediatric acute leukaemias and implications for management of patients
- (2010) Tomasz Szczepański et al. LANCET ONCOLOGY
- Suppression of inflammation by a synthetic histone mimic
- (2010) Edwige Nicodeme et al. NATURE
- Selective inhibition of BET bromodomains
- (2010) Panagis Filippakopoulos et al. NATURE
- Crosstalk between leukemia-associated proteins MOZ and MLL regulates HOX gene expression in human cord blood CD34+ cells
- (2010) J Paggetti et al. ONCOGENE
- Histone H3K27ac separates active from poised enhancers and predicts developmental state
- (2010) M. P. Creyghton et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of the DOT1L Network: Implications of Diverse Roles for DOT1L
- (2010) Geunyeong Park et al. PROTEIN JOURNAL
- The structure of the FYR domain of transforming growth factor beta regulator 1
- (2010) María M. García-Alai et al. PROTEIN SCIENCE
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- (2009) B. V. Balgobind et al. BLOOD
- Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
- (2009) Soyoung Lim et al. CARCINOGENESIS
- The molecular biology of mixed lineage leukemia
- (2009) R. K. Slany HAEMATOLOGICA
- On the Mechanism of Multiple Lysine Methylation by the Human Mixed Lineage Leukemia Protein-1 (MLL1) Core Complex
- (2009) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genome-wide reduction in H3K9 acetylation during human embryonic stem cell differentiation
- (2009) Jana Krejčí et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Global Analysis of H3K4 Methylation Defines MLL Family Member Targets and Points to a Role for MLL1-Mediated H3K4 Methylation in the Regulation of Transcriptional Initiation by RNA Polymerase II
- (2009) P. Wang et al. MOLECULAR AND CELLULAR BIOLOGY
- Brd4 Marks Select Genes on Mitotic Chromatin and Directs Postmitotic Transcription
- (2009) Anup Dey et al. MOLECULAR BIOLOGY OF THE CELL
- Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemia
- (2009) I. Radtke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes
- (2008) Akihiko Yokoyama et al. CANCER CELL
- H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
- (2008) Andrei V. Krivtsov et al. CANCER CELL
- Structure of WDR5 Bound to Mixed Lineage Leukemia Protein-1 Peptide
- (2008) Anamika Patel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2
- (2008) C Bach et al. ONCOGENE
- Insights from clinical studies into the role of the MLL gene in infant and childhood leukemia
- (2007) Tanzina Chowdhury et al. BLOOD CELLS MOLECULES AND DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search